Periimplant alterations under cyclosporin a drug treatment
Günay, H.; Evers, B.
Deutsche Zahnarztliche Zeitschrift 46(7): 499-503
1991
ISSN/ISBN: 0012-1029 PMID: 1817917 Document Number: 372562
One titanium implant of the Brånemark system and one Al2O2 ceramic implant each were inserted in the lower jaws of 6 Beagle dogs to evaluate the alterations of the periimplant tissues under CsA therapy. During the 3-6 months of CsA substitution hyperplastic alterations were observed as soon as after the 3rd week. These anomalies were most pronounced around the titanium implants.
Document emailed within 1 workday
Related Documents
Gunn, H.C.; Ryffel, B. 1986: Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis Clinical and Experimental Immunology 64(2): 234-242Martinova, Y.S.; Nikolova, D.B. 1990: Ultrastructural alterations in mouse spermatogenic cells after treatment with anticancer drug biocarbazine Zeitschrift für Mikroskopisch-Anatomische Forschung 104(6): 969-974
Nagar, R.; Chaturvedi, U.C.; Kumar, A.; Mathur, A. 1985: Abrogation of dengue virus-induced alterations of Fc-receptor functions of macrophages by splenectomy or drug treatment Indian Journal of Medical Research 81: 537-546
Tillement, J.P.; Albengres, E. 1995: Cyclosporin a and ketoconazole, drug interaction or therapeutical combination? Therapie 50(3): 185-189
Abe, C. 1985: Drug therapy of vasculitis with immunosuppressive agents, immunomodulators and cyclosporin a Nihon Rinsho. Japanese Journal of Clinical Medicine 43(10): 2196-2199
Leibbrandt, D.M.; Day, R.O. 1992: Cyclosporin and calcium channel blockers: an exploitable drug interaction? Medical Journal of Australia 157(5): 296-297
Sabaté, I.; Griñó, J.; Castelao, A.M.; Ortolá, J. 1988: Evaluation of cyclosporin-verapamil interaction, with observations on parent cyclosporin and metabolites Clinical Chemistry 34(10): 2151
Kroczek, R.A.; Black, C.D.; Barbet, J.; Shevach, E.M. 1987: Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens Journal of Immunology 139(11): 3597-3603
Felder, R.A.; Mifflin, T.E.; Bastani, B. 1986: An optimized method for measuring cyclosporin a with 125I-labeled cyclosporin Clinical Chemistry 32(7): 1378-1382
Lipkin, G.W.; Tucker, B.; Giles, M.; Raine, A.E. 1993: Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients Journal of Hypertension 11(4): 439-442
Michowitz, M.; Dayan-Avidan, G.; Bar-Shira-Maymon, B.; Donin, N.; Leibovici, J. 1994: Drug resistance and its counteraction by cyclosporin A in function of metastatic potential in the Lewis lung carcinoma system Cellular and Molecular Biology 40(4): 551-560
Kosugi, A.; Sharrow, S.O.; Shearer, G.M. 1989: Effect of cyclosporin A on lymphopoiesis. I. Absence of mature T cells in thymus and periphery of bone marrow transplanted mice treated with cyclosporin A Journal of Immunology 142(9): 3026-3032
Vermes, I.; Telegdy, G. 1973: Adrenal function following drug-induced alterations of the hypothalamic serotonin content Acta Physiologica Academiae Scientiarum Hungaricae 43(2): 105-114
Turco, G.; Ferrari Parabita, S.; Sacco, M.; Re, G. 1988: Hypertrophic gingivitis caused by cyclosporin A. 30 months' clinical experience in the use of cyclosporin a in patients undergoing cadaver kidney transplantation, with special attention to the proven side effects at the gingival level Minerva Stomatologica 37(12): 1043-1050
Weiss, G.B. 1979: Delineation of drug induced alterations in calcium distribution in vascular smooth muscle Proceedings of the Western Pharmacology Society 22: 333-338
Naik, Y.S.; Hasler, J.A. 1995: Intensity of Schistosoma mansoni infection determines alterations in hepatic drug metabolism Journal of the Egyptian Society of Parasitology 25(1): 157-163
Marutaka, M.; Iwagaki, H.; Suguri, T.; Tanaka, N.; Orita, K. 1994: Alterations of membrane fluidity in K562 cells exposed to the anticancer drug adriamycin Research Communications in Molecular Pathology and Pharmacology 85(2): 163-170
Lasorella, A.; Iavarone, A.; Israel, M.A. 1995: Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance Cancer Research 55(20): 4711-4716
Ochiai, T.; Naito, K.; Murakami, O.; Ohno, K.; Sekita, K.; Furuya, T.; Kurokawa, Y.; Matsumoto, K.; Saito, Y.; Hachisuka, A. 1993: Evaluation of immunotoxicity tests using cyclosporin A-treated rats: the International Collaborative Immunotoxicity Study II (cyclosporin A) Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 1993(111): 91-99
Büsch, R.; Ruzicka, T.; Donhauser, G. 1990: Cyclosporin a treatment of Behçet's disease Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 41(4): 229-231